Fundraising Fox
MEDSHAPE, INC.
Atlanta, US · 10 employees on LinkedIn · 1 known investors
Find your way into MEDSHAPE, INC.
Sign up to see every warm intro you have to MEDSHAPE, INC.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MEDSHAPE, INC. team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
Founders & leadership
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2014
▶$700KraisedAug 2014 · 2 investors · BiotechnologyRule 506(b)
- Niles NoblittDirector
- Paul F. HillsDirector
- Offering amount
- $4M
- Amount sold
- $700K
- Minimum investment
- $100K
- First sale
- Jul 2014
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $191K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $149.5K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $920.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2009 | $839.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $159.1K |
| National Science Foundation | Phase II | 2008 | $499.8K |
| National Science Foundation | Phase I | 2008 | $99.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $97.5K |
| National Science Foundation | Phase I | 2007 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MEDSHAPE, INC. do?
- MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
- Who are MEDSHAPE, INC.'s investors?
- MEDSHAPE, INC.'s investors include In-Q-Tel.
- How much funding has MEDSHAPE, INC. raised?
- MEDSHAPE, INC. has disclosed $700K raised across 1 round.
- Where is MEDSHAPE, INC. headquartered?
- MEDSHAPE, INC. is headquartered in Atlanta, US.